Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients
Abstract Lithium is the gold standard therapy for Bipolar Disorder (BD) but its effectiveness differs widely between individuals. The molecular mechanisms underlying treatment response heterogeneity are not well understood, and personalized treatment in BD remains elusive. Genetic analyses of the li...
Guardado en:
Ejemplares similares
-
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders
por: Sigrid Le Clerc, et al.
Publicado: (2021) -
Nonhomologous Recombination between Defective Poliovirus and Coxsackievirus Genomes Suggests a New Model of Genetic Plasticity for Picornaviruses
por: Barbara Holmblat, et al.
Publicado: (2014) -
A Literature Review of Personalization Transparency and Control: Introducing the Transparency–Awareness–Control Framework
por: Claire M. Segijn, et al.
Publicado: (2021) -
Host phylogeny determines viral persistence and replication in novel hosts.
por: Ben Longdon, et al.
Publicado: (2011) -
Regional differences in clonal Japanese knotweed revealed by chemometrics-linked attenuated total reflection Fourier-transform infrared spectroscopy
por: Claire A. Holden, et al.
Publicado: (2021)